Tag: HCPCS codes
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
OpenFDA and FAERS APIs: How to Access Side Effect Data and Signals
Jun, 1 2026
Leukeran Explained: Dosage, Uses, Side Effects & FAQs
Sep, 21 2025
FDA Inspection of Generic Manufacturing Facilities: What to Expect
Mar, 5 2026
How Hypocalcemia and Hypomagnesemia Influence Each Other
Oct, 3 2025
TZD Weight Gain and Edema: How to Manage These Common Side Effects
Dec, 24 2025